A Study of TLN-121 Given Alone and in Combination With Other Drugs for People With Non-Hodgkin Lymphoma

Full Title

An Open-Label, Multicenter, Phase 1 Trial to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of TLN-121 as a Single Agent and in Combination with Other Antilymphoma Agents, in Patients with Relapsed or Refractory Non-Hodgkin Lymphomas

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Steven Horwitz’s office at 646-608-3725.